Current Research Studies
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn’s Disease
CAMEO
What is the goal of the study?
With the CAMEO study we will focus on patients receiving optimized anti-TNF therapy within 180 days of diagnosis by utilization of frequent drug level monitoring and pharmacokinetic based dosage guidance, formalizing intestinal re-evaluation at standardized time-points with central adjudication, and fully characterizing the biologic profile of all participants.
Who can participate in the study?
Please contact the study team listed below to learn more.